Christophe Duhayer

Christophe joined Johnson & Johnson 20 years ago and has held several roles of increasing responsibility across Johnson & Johnson Medical Devices in Europe, Middle East & Africa, and Latin-America. In 2014, Christophe temporary left Johnson & Johnson to work for Smith & Nephew as General Manager, SYNCERA, Middle East, North Africa, Turkey, Russia & CIS, based in Dubai.

In his current role, Christophe leads Johnson & Johnson Medical Devices France companies (Ethicon, DePuy Synthes, Biosense Webster, Cerenovus and Mentor) which develop innovative technologies in surgery, orthopaedics and interventional solutions, helping to save lives and paving the way to a healthier future for everyone, everywhere.

Christophe is a board member of the SNITEM (Syndicat National de l'Industrie des Technologies Médicales), the French Medical Devices Trade Association.

Christophe holds a Master in International Business from the Business School of Bordeaux (Kedge), and from the European Business School of Madrid (EBP Madrid - Spain).

Healthcare should put patients at the heart of decision-making, while delivering benefits for society as efficiently as possible. This, I believe, was clear before the pandemic. However, the additional strain under which our systems must operate at present, as well as additional demands for resources, make the case for value-based healthcare (VBHC) stronger than ever before. Even before COVID-19 dominated our thoughts and global news headlines, the World Health Organization (WHO) estimated that between 20% and 40% of all global health spending is currently wasted through inefficiency. Clinicians and health systems are under intense pressure to improve health outcomes, increase patient satisfaction, and improve HCP satisfaction while reducing costs with often outdated, over-stretched and under-financed delivery structures. Couple this with the ongoing COVID-19 pandemic and it’s clear to see the challenges faced when striving to create high-quality and sustainable healthcare across Europe. To me, the time has come to embrace VBHC. Measuring clinician- and patient-reported outcomes, integrating this data into the process of care and devising new procurement models can help us to better coordinate the patient journey. Every hospital within every health system in every country is unique, yet the goal should always be to achieve the best possible outcome for each patient. I don’t believe that off-the-shelf solutions will work universally. It is vital that healthcare providers identify the biggest challenges and then team up with hospital administrative leadership and others (health authorities, healthcare companies, insurers etc.) to co-create bespoke solutions that fit their needs. Combined with outcome measurement, resource allocation collection shows where unnecessary waste can be prevented. Technologies can help by tracking and streamlining supply chains, and by integrating clinical best practice. This can reduce high treatment costs that could arise later. Data and insights I believe an insight-driven approach helps health systems identify and optimize...